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RESUMO 
 
O monóxido de carbono (CO) é um gás altamente tóxico, sem cor, sabor ou cheiro. É 
formado quando há combustão incompleta de matéria orgânica. Aproximadamente 40% do 
CO atmosférico provém de fontes naturais e os restantes 60% da intervenção humana., 
mas também pode ser gerado endogenamente. As intoxicações por CO são uma realidade 
comum, resultando em mais de 50000 admissões urgentes nos EUA. Em Portugal, as 
intoxicações por CO não são muito comuns, mas não devem ser desprezadas. A toxicidade 
do Co está relacionada com a sua interação com a hemoglobina (Hb), formando o 
complexo carboxihemoglobina (COHb), levando a um comprometimento do transporte de 
oxigénio para tecidos periféricos. 
Um método espectrofotométrico para quantificação de COHb foi validado de acordo 
com a European Medicines Agency. O limite de deteção (LOD), limite de quantificação 
(LOQ), precisão (%CV), exatidão e linearidade do método foram determinados. Após 
colheita, o sangue foi misturado com fluoreto de sódio (NaF) 2.5% e separado em 2 tubos 
contendo solução hemolítica – um foi borbulhado com oxigénio e outro borbulhado com 
CO. Quantidades apropriadas destas soluções foram misturadas para a preparação de 
soluções de concentrações conhecidas. Posteriormente, todas as soluções padrão foram 
misturadas com ditionito de sódio para promover a redução e analisadas por 
espectrofotometria UV/Vis a 420 e 432 nm. Foi verificada linearidade para concentrações 
de COHb entre 0-100%, com r2≥0.98. A %CV intra e interdia foram inferiores a 15%. A 
percentagem de recuperação apresentou valores entre 89.3-117.3, com um desvio padrão 
de 10.1%. LOD e LOQ variaram entre 0.9-1.4%. 
Para análise da estabilidade da COHb, amostras de sangue foram armazenadas a três 
temperaturas diferentes [temperatura ambiente (RT), 4ºC e -20ºC] e analisados com NaF 
– simulando um intoxicação fatal, e sem NaF – simulando uma intoxicação não-fatal. Nas 
amostras com %COHb correspondente a uma intoxicação não-fatal, a -20ºC e 4ºC não 
ocorreram variações na concentração de COHb entre a primeira análise e posteriores 
reanálises. À RT ocorreu uma variação negativa de 21,4% em relação ao valor inicial. Nas 
amostras com %COHb correspondente a uma intoxicação fatal tiveram o mesmo 
comportamento a -20ºC e a 4ºC. Já à RT ocorreu um aumento de 21,1% em comparação 
com o valor inicial. Concluindo, um método espectrofotométrico para quantificação da 
%COHb foi validado. A %COHb não sofreu variação ao longo do tempo a -20ºC e a 4ºC. 
RT não é uma temperatura de armazenamento recomendada para a quantificação de 
%COHb e o NaF parece não ter influência na sua estabilidade, 
Palavras-chave: monóxido de carbono, fluoreto de sódio, validação de método, 
estabilidade 
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ABSTRACT 
 
Carbon monoxide (CO) is a highly toxic, colorless, tasteless and odorless gas. It is 
formed when there is incomplete combustion of organic matter. Approximately 40% of 
atmospheric CO comes from natural sources and the remaining 60% comes from human 
activities. CO can also be generated endogenously. CO intoxications are a common reality, 
resulting in over 50000 emergency admissions in USA. In Portugal, CO intoxications are 
not very common, but cannot be overlooked. CO toxicity is mainly related with its interaction 
with hemoglobin (Hb) forming carboxyhemoglobin (COHb) and leading to a compromise of 
oxygen transportation to peripheral tissues. 
A spectrophotometric method for quantification of COHb was validated accordingly to 
European Medicines Agency. The limit of detection (LOD), limit of quantification (LOQ), 
precision (%CV), accuracy and linearity of the method were determined. After collection, 
blood was mixed with sodium fluoride (NaF) 2.5% and separated in 2 tubes containing 
hemolysis solution – one was bubbled with oxygen and the other bubbled with CO. 
Appropriate amounts of these solutions were mixed in order to prepare standard solutions 
of known concentrations. Subsequently, all standards solutions were mixed with sodium 
dithionite to promote a reduction and analyzed by UV/Vis spectrophotometry at 420 and 
432 nm. Linearity was verified in a concentration range from 0-100% of COHb, with r2≥0.98. 
The %CV intra and inter-day were below 15%. The recovery percentage ranged from 89.3-
117.3%, with a deviation of 10.1%. LOD and LOQ varied from 0.9-1.4%. 
In order to analyze the stability of COHb, blood samples were stored at three 
temperatures (room temperature (RT), 4ºC and -20ºC) and analyzed with NaF – simulating 
a fatal intoxication, and without NaF – simulating non-fatal intoxication. In non-fatal 
intoxication samples, at -20ºC and 4ºC there was no variation in COHb concentration 
between first analysis and posterior re-analysis. At RT there was a negative variation of 
21.4% relatively to initial value. Fatal intoxication samples exhibited the same behavior at -
20ºC and 4ºC. At RT, there was an increase of 21.1% in comparison to initial value.  
In conclusion, a spectrophotometric method for %COHb quantification was validated. 
The %COHb did not suffer variation throughout time at -20ºC and 4ºC. RT is not a 
recommended storage temperature for %COHb quantification and NaF seems not to have 
any relevance in the stability. 
 
Keywords: carbon monoxide, sodium fluoride, method validation, stability 
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1. INTRODUCTION 
 
Intoxications are one of the problems that affect people’s lives (Dinis-Oliveira et al., 
2013). In Portugal, the Centro de Informação Antivenenos (CIAV) received an average of 
77 calls per day related with intoxications, between 2001 and 2011. In 2011, in absolute 
numbers, the CIAV has registered 8,973 potential cases of intoxications in children until 15 
years old and 12,621 cases in adults, with the digestive tract representing 87% and 80% of 
cases, respectively (Dinis-Oliveira et al., 2013).  
According to World Health Organization (WHO) data, in 2012 an estimated 193,460 
people died worldwide from unintentional poisoning. In the same year, unintentional 
poisoning caused the loss of over 10.7 million years of healthy life (World Health 
Organization)  
Carbon monoxide (CO) poisonings are relatively common (Ernst and Zibrak, 1998; 
Hampson and Weaver, 2007) leading to about 50,000 hospital admissions per year in the 
USA. In Europe, CO-related deaths represent an annual death rate of 2.24/100,000 
population, with males more affected than females. 54.7% of deaths constitute unintentional 
deaths, and 38.1% constitute intentional deaths (Braubach et al., 2013). In Portugal, CO 
poisonings are not very common, but it should not be ignored (Hampson and Weaver, 2007; 
Sá et al., 2011). 
CO is a highly toxic gas that exists in atmosphere, which concentration vary from 0.1 
parts per million (ppm) in clean atmospheres to 5000 ppm in areas proximal to chimneys 
(Fawcett et al., 1992).  
There are two main sources of CO: external and endogenous. About 60% of external 
CO comes from human intervention, while the remaining 40% comes from natural sources 
(Uges, 2011; Varma et al., 2015). 
CO has been described as having physiological roles, namely as alleged 
neurotransmitter (although not completely proven), vasodilatation and platelet aggregation 
inductor. Being a gas, it does not depend on transporters to enter cells, so it can easily enter 
in it (Hartsfield, 2002; Snyder and Ferris, 2000; Varma et al., 2015). It also has a role in 
cardiac function, once it improves cardiac blood supply trough vascular tone relaxation in 
heart (Grill et al., 2003).  
The toxicity of CO is mainly related to its capacity to bind hemoglobin (Hb), leading to 
the formation of carboxyhemoglobin (COHb) (Nelson and Cox, 2008). Indeed, CO has an 
approximately 230-270 times greater affinity for Hb than oxygen (O2). Consequently, 
relatively low levels of CO can have substantial and tragic effects (Nelson and Cox, 2008). 
In fact, with approximately 15% of COHb mild symptoms are described, such as headache 
4 
 
and dizziness; after 40-50% of COHb loss of consciousness and potentially death may 
occur (Pillay, 2013). 
 
2. CARBON MONOXYDE PHYSICAL AND CHEMICAL PROPERTIES 
 
CO is a diatomic stable gas in atmosphere, tasteless, colorless, odorless and non-
corrosive (Varma et al., 2015; Wilbur et al., 2012). It has a molecular weight of 28.01 and it 
is very inflatable on air, in a wide range of concentrations. Below -191.53ºC CO is a liquid 
and at temperatures above 70ºC it is insoluble in water (George, 2001). When burned, it 
produces a blue flame (O'Neil et al., 2006). CO physical-chemical properties are described 
in Table 1. 
 
Table 1 – Physical and chemical properties of CO (adapted from Varma et al., 2015 and 
Wilbur et al., 2012). 
Property Description 
Chemical structure  
Physical state Gas 
Molecular weight 28.01 
Melting point -205 ºC 
Boiling point -191.53 ºC 
Density at 25ºC 1.145g/L 
Solubility:  
Water, 20ºC 2.3 mL/100 mL 
Organic solvents 
Relatively soluble in ethyl 
acetate, chloroform and acetic 
acid 
Explosive air limit 12.5-74.2 % 
 
 
3. SOURCES OF CARBON MONOXIDE 
 
3.1 External sources 
 
CO is formed when there is an incomplete combustion of organic matter. It is produced 
as main pollutant when fossil fuels and biomass (gas, charcoal, woods, etc) are burned with 
inadequate supply of oxygen (Smollin and Olson, 2010; Wilbur et al., 2012) Common 
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sources of CO are smoke from exhaustion vehicles, fire smokes and heating systems poorly 
ventilated and maintained (Uges, 2011). However, approximately 40% of atmospheric CO 
comes from natural sources, such as natural gas emissions, volcanic eruptions, vegetal and 
animal degradation and also natural forest fires (Varma et al., 2015). CO can also be formed 
through the photochemical oxidation of methane and other volatile compounds existent in 
the atmosphere (Wilbur et al., 2012). The remaining 60% comes from human activities, like 
consumption of fossil fuels, tobacco smoke and dumps (Jain, 1990; Varma et al., 2015; 
Vreman et al., 2000).  
Higher atmospheric levels of CO are observed in urban areas and also in places where 
there are permanent emission sources like gas, coal or petrochemical and also refineries 
(Wilbur et al., 2012). In the northern hemisphere, the average outdoor CO concentrations 
are about 0.12 ppm and in the southern hemisphere 0.04 ppm, with several changes 
throughout the year with highest levels verified during the winter (Wilbur et al., 2012). 
The development of countries are leading to an increase on migration of rural 
populations to urban areas, this can lead to an increase in atmospheric CO (Varma et al., 
2015). United States Environmental Protection Agency (EPA) set an environmental limit of 
10 mg/m3 (9 ppm) of CO in air in not less than 8 hours, a limit that can only be exceeded 
once a year (Wilbur et al., 2012). 
Luckily, atmospheric CO has not exceeded safety level globally or in any specific areas 
(e.g., Mexico City or Los Angeles), but it is a possibility. Many efforts must be done by the 
governments worldwide to reduce CO emissions (Varma et al., 2015). 
 
3.2 Endogenous sources 
 
CO can also be generated endogenously. Normal CO levels in plasma is in the range 
1% to 5% and may rise up to 7% to 8% in smokers (Pillay, 2013) The greatest endogenous 
source of CO in healthy individuals is the degradation of heme group from erythrocytes to 
biliary pigments, catalyzed by heme-oxygenases (HO) (Ryter et al., 2006a; Varma et al., 
2015). Tissues that can express HO can contribute to CO production, such as the spleen, 
liver and reticuloendothelial system, once they are the major location of heme metabolism 
(Wilbur et al., 2012). The net rate of endogenous CO production has been expected to be 
about 0.42 mL CO at standard temperature and pressure (Wilbur et al., 2012; Wu and 
Wang, 2005) 
There are three isoforms known of HO: HO-1 (inducible) and HO-2 and HO-3 (both 
constitutive) (Ryter et al., 2002; Wilbur et al., 2012) Induction of HO-1 raises the production 
of CO, while inhibition HO expression/activity reduces CO production (Ryter et al., 2006b; 
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Ryter et al., 2002; Wilbur et al., 2012). A small portion (20%) of endogenous CO is 
generated from other hemoproteins, like myoglobin and other iron-containing proteins 
(Varma et al., 2015; Vreman et al., 2000). The endogenous-generated CO has been 
descripted in literature as a molecular chemical signal involved in several cellular functions, 
as proliferation, apoptosis and inflammation, and also defined as a neurotransmitter of the 
central nervous system (Lascaratos and Marketos, 1998; Prockop and Chickova, 2007). 
 
4. PHYSIOLOGICAL ROLES OF CO 
 
Studies on CO physiological roles are relatively recent and it comes that CO may be 
on par with oxide nitric (NO) (Varma et al., 2015). 
NO and CO have many common properties: both are gases, putative 
neurotransmitters, cause vasodilatation, increase cyclic guanosine monophosphate 
(cGMP), inhibit platelet aggregation and are synthesized endogenously, though CO had 
many exogenous sources (Hartsfield, 2002; Snyder and Ferris, 2000; Varma et al., 2015). 
As gases, both do not directly depend on plasma membrane transporters to enter cells 
(Varma et al., 2015). NO increases HO-1 gene expression and consequently CO formation 
(Hartsfield et al., 1997). Localization of HO-2 (enzyme responsible for releasing CO from 
COHb), and guanylyl cyclase in isolated brain parts absent in NO, joined with modifications 
in cGMP by agents and processes that modify CO, has been advanced as proof for a 
putative neurotransmitter role for CO (Verma et al., 1993). It is an evidence that when CO 
is released from heme breakdown it can increase cGMP. But, a neurotransmitter must 
transmit a message across a synapse, so, CO should only be treated as a putative non-
proven neurotransmitter (Varma et al., 2015). 
In cardiac terms, hypoxia-induced up-regulation of HO-1 in heart increase CO 
production, leading to an improvement in cardiac blood supply through vascular tone 
relaxation in heart, constituting a cardiac defense mechanism (Grill et al., 2003) 
Regarding to vascular contractility, the process of CO-induced vasodilatation was first 
described by McGrath and Smith (McGrath and Smith, 1984), who showed that occurs 
relaxation of rat coronary artery when exposed to exogenous CO. The vasodilatation 
consequence of endogenous CO was described as inhibition of HO activity with 
metalloporphyrins either increased perfusion pressure of isolated rat liver (Suematsu et al., 
1994) or decreased the diameter of pressurized gracillis muscle arterioles (Kozma et al., 
1999; Wu and Wang, 2005). 
Studies showed that CO also can inhibit platelet aggregation. Platelet release of 
adenosine diphosphate (ADP) and serotonin can be inhibited by CO (Mansouri and Perry, 
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1984; Wu and Wang, 2005). The inhibitory effect on platelet aggregation by CO is principally 
intermediated by activation of cGMP pathway (Wu and Wang, 2005). There is also 
described that CO improve the production of proinflammatory cytokines and interleukin-10 
from monocytes (Otterbein et al., 2000). 
 
5. EPIDEMIOLOGY 
 
CO intoxications are relatively common and death can occur by intentional or 
unintentional ways (Mayes, 1993; Prockop and Chichkova, 2007), resulting in over 50,000 
emergency admissions in USA per year (Hampson and Weaver, 2007). It is documented 
that CO intoxications are more frequent in females, with ages under 17 and during winter 
months (November to March). In USA in 2005, 24,891 cases of suspected CO-related 
hospitalization were reported, but only 17% were confirmed as CO intoxication (Iqbal et al., 
2012). 
In Europe, it is estimated that hundreds of deaths occur every year by CO inhalation 
(Braubach et al., 2013). In a study performed between 1980 and 2008, were reported by 28 
countries 140,490 deaths related with CO inhalation. The annual death rate associated was 
2.24 per 100,000 population (Braubach et al., 2013). In total, CO exposure involved a total 
of 31,473 hospital admissions, with an average of 342 admissions per year. Males are the 
more common victims of CO-related deaths. The largest share of mortality is found for the 
age group of 25-64 years old (63.2%), but data indicate that the population aged 65 years 
old or older is the most affected (22.3%) (Braubach et al., 2013). Unintentional deaths 
constitute 54.7% of all the deaths, with 35.9% related with accidental CO exposure. 
Intentional deaths represent an average of 38.1% of all deaths (Braubach et al., 2013). 
In Portugal, the first epidemiological study was performed by Sá and collaborators (Sá 
et al., 2011). The study was based in the data on CO intoxications admissions between 1st 
January 2000 and 31st December 2007. 621 admissions at national level were verified, with 
a significant increase in winter months, as already described in literature (Sá et al., 2011; 
Wilson et al., 1998). A considerable percentage of accidents occurred with children, which 
may represent negligence and lack of information from parents and tutors (Sá et al., 2011). 
Concerning the elderly, there is no report of an increase of this kind of intoxications. Also 
only 2.1% of intoxications were intentional. 
With this study it was possible to conclude that CO intoxications are not a very frequent 
problem in Portugal, but cannot be overlooked (Sá et al., 2011). 
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6. TOXICITY MECHANISMS 
 
CO toxicity is related with its interaction with Hb. CO is rapidly absorbed by lungs and 
once in the bloodstream, CO rapidly binds to Hb with an affinity 230 to 270 higher than 
oxygen. This leads to an inadequate partial pressure of O2 and there is a reduction in arterial 
oxygen content (Pillay, 2013). When CO binds to Hb, occurs the formation of the complex 
COHb (Guzman, 2012; Pillay, 2013; Prockop and Chickova, 2007; Varma et al., 2015). 
Further, CO causes a leftward shift of the oxyhemoglobin (O2Hb) dissociation curve, 
affecting this way the offloading of O2 from Hb to tissues (Pillay, 2013) 
The CO-binding also leads to an allosteric alteration in the Hb molecule (Figure 1), 
increasing its affinity to oxygen and consequently the O2 molecule cannot be released, 
compromising its transportation to peripheral tissues (Guzman, 2012; Prockop and 
Chickova, 2007; Weaver, 2004). This effect  is known as Haldane effect (Collier, 1976). The 
great affinity of CO to Hb also improves the binding of CO to Hb, compromising the binding 
of oxygen, resulting in a decrease of oxygen in circulation. Furthermore, the dissociation of 
the complex COHb is very slow (Renwick and Walton, 2001; Varma et al., 2015). Both 
mechanisms lead to a decrease of oxygen availability and consequently to hypoxia 
(Guzman, 2012). 
 
 
Figure 1: Effect of CO in O2 binding: when CO enters the erythrocyte, besides the fact that 
it blocks O2 binding to Hb, it also causes an allosteric alteration in Hb, which cannot 
dissociate O2. This leads to a compromise in O2 transportation to peripheral tissues, leading 
to a hypoxic situation. 
O2 is no longer carried
CO
Hb
O2
Hb functionally binding 
O2
When CO enters the erythrocyte, O2 can not 
be transported, and the O2 binding to Hb can 
no longer dissociate 
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CO can still bind to other heme-containing proteins than Hb, whose function may be 
modified by the presence of CO, such as cytochrome c oxidase (Figure 2), impairing 
metabolism and mitochondrial respiration, myoglobin and neuroglobin, interfering in O2 
storage and utilization in muscle and brain, and platelet hemoproteins (Alonso et al., 2003; 
Bauer and Pannen, 2009; Guzman, 2012; Kao and Nanagas, 2006; Miro et al., 2000; 
Omaye, 2002; Wilbur et al., 2012). CO can also interfere in NO cell signaling pathway, 
cellular redox balance and reactive oxygen species, steroid and drug metabolism 
(cytochrome P450) and prostaglandin cell signaling pathway (Wilbur et al., 2012) 
 
Figure 2: Effect of CO in cytochrome c oxidase. Electron transference from cytochrome c 
oxidase to O2 is blocked, leading to a breakdown of O2 supply, aggravating the hypoxia. 
 
7. SIGNS AND SYMPTOMS AFTER POISONING 
 
The main symptoms that occur in a CO acute exposure are described in Table 2. The 
principal mechanism of toxicity caused by CO exposure is tissue hypoxia, so tissues with 
higher demand for O2 are the most vulnerable, like brain or heart (Bauer and Pannen, 2009; 
Chavouzis and Pneumatikos, 2014; Wilbur et al., 2012). 
CO intoxications are usually categorized in: mild, moderate and severe. Signs and 
symptoms in a mild intoxication include nausea, dizziness, vision disturbances, headache, 
dilatation of cutaneous musculature and occasionally cherry lips and skin (Wilbur et al., 
2012). In a moderate CO intoxication confusion, chest pain, tachycardia, weakness, 
dyspnea may appear (Wilbur et al., 2012). In a severe CO intoxication symptoms include 
hypotension, cardiac and respiratory arrest, seizures, coma and possible death (Wilbur et 
al., 2012). 
 However, the effects of CO are not confined to the exact period after exposure and 
cases of delayed-onset and persistent neurological impairs have been reported. This 
Cytochrome c 
Oxidase
IV
2 H+ O2
2e- 2e-
H2O
CO
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development may take place from some days to about 3-4 weeks after exposure (Choi, 
1983; Garland and Pearce, 1967; Kao and Nañagas, 2004; Lee and Marsden, 1994; Min, 
1986; Myers et al., 1985; Thom and Keim, 1989; Wilbur et al., 2012). Additionally, it was 
described a syndrome of apparent recovery from an acute CO poisoning followed by a 
neurological and behavioral worsening after a latency period of 2 to 40 days, with symptoms 
transversal to almost any kind of neurological/psychiatric impair, as memory loss, seizures, 
hallucinations, psychosis and motor disturbances  (Choi, 1983; Garland and Pearce, 1967; 
Kao and Nañagas, 2004; Lee and Marsden, 1994; Min, 1986; Myers et al., 1985; Thom and 
Keim, 1989). In the majority of the cases, long-term prognosis is good and symptoms have 
tendency to be progressively resolved (Chiew and Buckley, 2014). 
In order to identify long-term neurological damages due to CO exposure, neurological 
injuries or loss of consciousness must be considered, although other means of identification 
of these symptoms in individuals may be required, once it can be difficult to know if there is 
history of loss of consciousness (Chiew and Buckley, 2014). 
With this idea of identification of long-term neurological impairs, prediction tools have 
been studied, like the new calcium-binding protein (S100B) present in astrocytes, which is 
released after hypoxic injury as consequence of neuronal and astrocyte cell death (Chiew 
and Buckley, 2014). In a study performed in Taiwan by Park and collaborators (Park et al., 
2012), 71 patients were involved and 10 of those patients developed delayed neurological 
impair. The study showed that those patients with neurological impair showed longer loss 
of consciousness and higher levels of S100B, being this protein a useful tool when it comes 
to evaluate a CO poisoning (Park et al., 2012). 
 
Table 2 – Principal signs and symptoms in acute CO intoxications (based in Nelson and 
Cox, 2008). 
% COHb Principal symptoms 
<10% Not observed 
~15% Mild headaches 
20-30% Severe headaches, nausea, dizziness, visual 
disturbances 
30-50% Severe neurological alterations 
50%-60% Loss of consciousness, coma 
>60% Death 
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8. FORENSIC RELATED ASPECTS 
 
8.1 Autoptic findings 
 
Autopsy findings in CO deaths are characteristic and may have an important role to 
determine the cause of death (Dinis-Oliveira et al., 2010b). Figure 3 shows the cherry-red 
or bright-pink colour of body lividity as the consequence of COHb formation, although similar 
lividity could develop in case of a cyanide poisoning (Dinis-Oliveira et al., 2010b). 
 
 
Figure 3: Lividity of cherry-red/bright-pink color in a Caucasian individual, as consequence 
of COHb formation (reproduced from Dinis-Oliveira et al, 2010, with permission).  
 
8.2 Collection and sample preservation 
 
Sample collection and preservation has an important role in forensic cases (Negrusz 
and Cooper, 2013). A mandatory first step that must be done in sample collection is to 
ensure that containers are correctly labelled to eliminate any doubt about the sample origin 
(Moffat et al., 2011). After collection, specimens must be stored in sealed and well filled 
containers at -4ºC for short-term storage and -20ºC (or -80ºC) for long term storage (more 
than a week) (Dinis-Oliveira and Magalhães, 2013). All samples must be accessible only to 
authorized staff. All this it is done to assuring the security and integrity of samples, insuring 
the possibility of a future use (Negrusz and Cooper, 2013). In other words, chain of custody 
should be accomplished. 
 Preservatives are not usually necessary in specimens other than blood and it is 
recommended to keep an unpreserved sample as well as a preserved blood (Skoop, 2004). 
The preservatives mostly used are sodium fluoride (NaF) or potassium fluoride (KF). NaF 
is mainly used and a final concentration of 1-5% by weight is recommended (Dinis-Oliveira 
et al., 2010a; Negrusz and Cooper, 2013; Prouty and Anderson, 1987). 
12 
 
Fluoride preservation is mainly added to inhibit microorganism mediated conversion of 
glucose to ethanol and microorganism mediated oxidation of ethanol, conversion of cocaine 
to ecgonine methyl ester by pseudocholinesterases, enzymatic loss of others esters such 
as 6-acetylmorphine, GHB production in stored samples, among others (Dinis-Oliveira et 
al., 2010a). 
It is also important to properly maintain a chain of custody, to insure that the 
sample/evidence has remained intact, and not been adulterated, changed or misplaced in 
any way that could compromise its integrity (Dinis-Oliveira and Magalhães, 2013)  
 
9. ANALYTICAL METHODS USED FOR CO/%COHb DETERMINATION 
 
The analysis of CO in blood has been of great interest for many years and various 
techniques have been used (Boumba and Vougiouklakis, 2005; Widdop, 2002). The 
classical methods used for CO analysis are summarized in Table 3. 
 
Table 3 – Classical methods used for CO determination (adapted from Widdop, 2001). 
Methods Description 
Volumetric           
(Horvath and 
Roughton, 1942; 
Nicholas, 1951) 
This technique was first described by Van Slyke and collaborators 
(Slyke et al., 1923) and it became known as Van Slyke blood gas 
apparatus. A blood sample is put in a chamber with buffer and 
sodium dithionite. Nitrogen and oxygen are released in the chamber 
- oxygen is reduced (by sodium dithionite) and nitrogen is expelled. 
CO and CO2 are released with ferricyanide. CO2 is absorbed with 
sodium hydroxide and the residual volume of CO is measured 
(Feldstein, 1967; Slyke et al., 1923); it is very time consuming and 
there is the need of a specific apparatus. 
Colorimetric 
(Feldstein, 1967) 
This method uses an alkaline solution of the silver salt of p-
sulphaminobenzoic acid and CO reacts with it, forming a silver 
colloidal solution. The absorbance of this solution is proportional to 
CO concentration in the sample.  
Simple 
comparative 
color test    
(Maehly, 1962; 
Widdop, 2002) 
This method is based in direct visual comparison; blood from CO 
poisoning victims has a cherry-red color, although a normal color 
does not excludes poisoning; it can be compared a blood sample 
diluted with ammonia and normal blood treated the same way: a 
pink hint opposed to the straw of normal blood suggests that COHb 
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is present; It is a very simple method, but has very poor accuracy 
and cyanide poisonings give the same results. 
Microdiffusion in 
Conway cell  
(Feldstein and 
Klendshoj, 1957) 
This method uses a Conway cell (“petri” dish with an inner and outer 
well); a blood sample is placed in the outer well, the acid sulfuric is 
put in contact with blood and makes release CO, which reacts with 
a solution of palladium chloride in the inner well; although it is 
inexpensive and can work as a rapid semi quantitative test, it 
requires skill to place the components correctly in the wells. 
Hartridge 
reversion 
spectroscope 
(Hartridge, 1922) 
A simple device allows to observe directly COHb and 
oxyhemoglobin absorption bands in a sample of diluted blood; this 
device is currently obsolete. 
CO: carbon monoxide; CO2: carbon dioxide; COHb: carboxyhemoglobin 
 
The most popular and widely used techniques are spectrophotometric and 
chromatographic methods with variable detection systems (Boumba and Vougiouklakis, 
2005).  
Spectrophotometric methods are among the most frequently used techniques for CO 
quantification in blood (Boumba and Vougiouklakis, 2005). It is based in the comparison of 
the absorbance spectra of COHb with that of oxyhemoglobin and/or reduced hemoglobin 
(Widdop, 2002). There are two dominant spectrophotometric methods used for CO 
quantification: 
 
a) Manual two-wavelength method using simple spectrophotometers 
Different hemoglobin derivatives (reduced (HHb), O2Hb, methemoglobin (MetHb), etc) 
absorb at different wavelengths. The blood sample is converted into a two-component 
system (COHb/HHb, usually) and analyzed at two different selected wavelengths, usually 
420 and 432 nm. Both O2Hb and MetHb are reduced, whereas COHb is not. This is an 
easy, rapid and simple method, but requires a reduction step (with sodium dithionite); main 
disadvantages are also the lack of precision and accuracy, as well as specificity for COHb. 
(Katsumata et al., 1982; Moffat, 1986; Zwart et al., 1981). 
 
b) Automated multi-wavelength using specialized spectrophotometers called CO-
oximeters 
This method provides differential spectrophotometric measures on hemolyzed blood 
samples. It can measure total Hb, COHb and other forms of Hb simultaneously. It requires 
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little sample preparation, has good precision and can do simultaneous reading within a 
minute. However at low levels of COHb the accuracy is limited.  (Brehmer and Iten, 2003; 
Brown, 1980; Brunelle et al., 1996; Dennis and Valeri, 1980; Lee et al., 2003; Mahoney et 
al., 1993; Zwart et al., 1981). Because CO-oximeters are highly automated, they not offer 
the ability of adaptation of wavelengths to particular values suitable for each sample, an 
ability that manual spectrophotometric method could offer (Boumba and Vougiouklakis, 
2005; Zwart et al., 1984) 
 
Gas-chromatographic (GC) methods are considered more sensitive and accurate than 
spectrophotometric ones (Widdop, 2002). Blood samples are usually subjected to lysis of 
erythrocytes and followed by the release of the CO bound to Hb, achieved usually by 
acidification. The quantity of CO found is related with the hemoglobin content of the sample 
(Boumba and Vougiouklakis, 2005; Verman et al., 1984; Widdop, 2002). Sulfuric and 
hydrochloric acids and potassium ferricyanide are the most used liberating agents. When 
used in combination with hemolytic agents, such as detergents and saponin, these agents 
provoke the fragmentation of the red cell membrane with liberation of the possible CO bound 
to Hb (Boumba and Vougiouklakis, 2005; Widdop, 2002). The CO released is subsequently 
directed to the reactor headspace, where the headspace gas is analysed by GC, with aim 
to separate from other gases (Boumba and Vougiouklakis, 2005). There are many different 
types of detection used in GC, specified in Table 4. Other methods have been described 
but they are not routinely used (Table 5). 
 
Table 4 – Types of detectors used in GC methods (based in Boumba and Vougiouklakis, 
2005). 
Type of detector Reference 
Flame ionization detector 
(after catalytic reduction of CO to 
CH4) 
(Constantino et al., 1986; Griffin, 
1979; Guillot et al., 1981; 
Katsumata et al., 1985) 
Thermal conductivity detector  
(Dam et al., 1994; Goldbaum et al., 
1986; Horvath et al., 1988) 
Infrared detection (Maas et al., 1970) 
Mercury vapor (Verman et al., 1984) 
Mass spectrometry  (Oritani et al., 2000) 
              CO: carbon monoxide; CH4: methane 
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Table 5 – Other methods used for COHb analysis (adapted from Widdop, 2001 and 
Boumba and Vougiouklakis, 2005). 
Method Principle Applications 
Fourier transform infrared 
spectrophotometry             
(Kijewski et al., 1985) 
Measurement of 
absorbance at 
characteristic bands 
Analysis of dried 
blood samples 
Differential protein 
precipitation 
(Whitehead and Worthington, 
1961; Wolff, 1947) 
Oxyhemoglobin heat 
precipitation at pH 5 
Clinical analysis 
of CO poisoning 
Derivative spectroscopy 
(Fukui et al., 1985; Fukui et al., 
1984; Panzali et al., 1987; Parks 
and Worth, 1985) 
A derivative 
spectrometry is used 
to eliminate non-
specific interferences 
Mainly forensic 
investigations 
 CO: carbon monoxide 
 
The main advantages and disadvantages of spectrophotometric and GC methods are 
described in Table 6, as they are the most used worldwide. 
Overall, the selection of the technique to quantify CO should be done carefully, taking 
into account the goal of analysis and all the conditions, such as quality/quantity/number of 
samples available, accuracy needed for the analysis and instrumentation available in the 
lab.  
 
Table 6 – Comparison between spectrophotometric and GC methods (adapted Boumba 
and Vougiouklakis, 2005).  
Method Advantages Disadvantages 
Spectrophotometric 
Little sample preparation 
Short analysis time 
Relatively low cost 
Ease and speed of operation 
(could be used in emergency 
situations) 
Errors due to interferences 
Not very accurate at 
COHb (< 5%) 
Requires the use of fresh 
blood 
GC 
Highly specificity for CO 
Not affected by interferences 
Very small samples volume 
High accuracy 
Considerable sample 
preparation 
Long-time analysis 
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Too demanding to 
routine/emergency 
quantifications 
CO: carbon monoxide; COHb: carboxyhemoglobin; GC: gas chromatography 
 
For the present work it was chosen a spectrophotometric manual double-wavelength 
(420 and 432 nm) method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
Objectives 
 
 
 
 
 
 
  
18 
 
  
19 
 
10. OBJECTIVES 
 
CO is a highly toxic, colorless, tasteless and odorless gas. CO toxicity is mainly related 
with its interaction with Hb forming COHb leading to a compromise of oxygen transportation 
to peripheral tissues. 
Quantification of COHb levels is an important procedure to confirm exposure to CO 
either in antemortem or postmortem cases, therefore a validation of a simple, accurate and 
precise method for COHb analysis is necessary. GC analysis is quite demanding, it requires 
long time analysis, and cannot be used in emergency situations, so in this study we decided 
for a spectrophotometric method due to the ease and speed of preparation. Additionally 
there aren’t enough studies of this method reported in the literature. 
During the improvement of the method, also was evaluated the stability of COHb in 
whole blood samples, to infer on how long the samples can be kept and used, leading to 
reliable results. There are several studies of COHb stability in literature, but there is not a 
comparison between blood samples with and without preservative for long periods of time, 
at three different temperatures.  
With this work, we aim to validate a spectrophotometric method for the %COHb 
quantification and to test the stability of %COHb in blood samples containing anticoagulant 
(ethylenediaminetetraacetic acid (EDTA)), with and without NaF 2.5%, stored at different 
temperatures: room temperature (RT), 4ºC and -20ºC, for a period of 6 months. 
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11. MATERIAL AND METHODS 
 
11.1 Reagents and standards 
 
Monopotassium phosphate (KH2PO4) and dipotassium phosphate (K2HPO4) were 
obtained from Merck™ (Darmstad, Germany). Sodium dithionite and NaF were obtained 
from Sigma-Aldrich™ (St. Louis, MO). Both oxygen and monoxide pump were obtained 
from Praxair (Madrid, Spain). Nitrogen pump was obtained from Air Liquid™. All the 
reagents used were of analytical grade or from the highest available grade. The equipment 
used was a Biotek Synergy™ microplate reader. 
 
 
11.2 Collection of blood samples 
 
Blood samples used in the method validation and stability study were collected 
voluntary prior to use (samples used in stability study were collected only once) from the 
same healthy, non-smoker, female individual. The collection was made in 4 mL tubes 
containing EDTA, provided by Green Vac-Tube™.  
 
 
11.3 Preparation of working solutions 
 
Buffer solution was prepared by dissolving 13.6g of KH2PO4 and 17.4g of K2HPO4 in 
1000 mL of distilled water. The pH was adjusted to 6.85 with a sodium hydroxide (NaOH) 
10N solution. Hemolytic solution was prepared by a 10-fold dilution of the buffer. Reducing 
solution was prepared always prior to use by mixing 0.0625g of sodium dithionite in 50 mL 
of buffer solution. 
 
 
11.4 Preparation of standards for calculation of factors F1, F2 and F3 and calculation 
of %COHb 
 
For the standards preparation, two blood pools were prepared: one of 100% O2Hb and 
other of 100% COHb. For this, 50 µL of blood were added to 6 mL of hemolytic solution and 
left for 10 minutes at RT to ensure total hemolysis. One pool was bubbled with ultrapure O2 
for 20 minutes and the other pool with CO for 2 minutes. After this bubbling, both pools were 
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bubbled with nitrogen for 2 minutes to remove any O2/CO undissolved. Then, 200 µL of 
these solutions were transferred to other tubes containing 2.3 mL of reducing solution and 
left for 10 min to ensure complete reduction. Absorbance (Abs) readings were made at 420 
and 432 nm as previously recommended (Beutler and West, 1984; Luchini et al., 2009). 
Factors were calculated as following: 
F1 =  
Abs432O2Hb
Abs420O2Hb
 
F2 =  
Abs432COHb
Abs420O2Hb
 
F3 =  
Abs420COHb
Abs420O2Hb
 
The %COHb in method validation and stability study was calculated based on the 
following formula: 
%𝐂𝐎𝐇𝐛 =  
1 −
Abs420
Abs432
× F1
Abs420
Abs432
 (F2 − F1) − F3 + 1
× 100 
 
These formulas were deducted by Beutler and West (Beutler and West, 1984). In 
general, because each factor equal the ratio of two molar absorptivities, the Hb 
concentration in the factors cancel each other out when the same Hb solution is converted 
completely to either reduced Hb or COHb (Beutler and West, 1984; Luchini et al., 2009). 
 
 
11.5 Method validation 
 
A full method validation should be performed for any analytical method whether new or 
based upon literature (Peters and Maurer, 2002). Analytical method validation is a 
mandatory step to evaluate the ability of developed methods to provide accurate results 
during routine application. The validation of the method was performed accordingly to the 
European Medicines Agency guidelines (European Medicines Agency, 2011). 
The linearity, limit of detection (LOD), limit of quantification (LOQ), precision and 
accuracy of the method were determined. In order to obtain these validation data, calibration 
curves were prepared by mixing appropriated volumes of hemolisated blood with CO or O2. 
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11.5.1 Linearity 
 
The response of the instrument with regard to the concentration of analyte should be 
known, and should be evaluated over a specific concentration range. The calibration 
standards should be prepared in the same matrix as the matrix of the intended study 
samples by spiking the blank matrix with known concentrations of the analyte. There should 
be one calibration curve for each analyte studied in the method validation and for each 
analytical run (European Medicines Agency, 2011). The method linearity was determined 
by evaluation of the regression curve (Abs at 420 and 432 nm versus analyte concentration) 
and expressed by the determination coefficient (r2) using spiked samples. Three 
independent calibration curves were obtained using 6 different concentrations of CO (0%, 
10%, 30%, 50%, 80% and 100%). In addition, a blank sample (processed matrix sample 
without analyte) was prepared. These concentrations were prepared daily as mentioned 
before. Linearity was accepted if r2≥ 0.98. 
 
11.5.2 Limit of detection and limit of quantification 
 
The LOD is the lowest concentration of analyte in a sample that can be distinguished 
from the blank (noise of the system). The LOQ is the lowest concentration of analyte in a 
sample which can be quantified reliably, with an acceptable accuracy (bias) and precision. 
LOD and LOQ were determined as following: 
blankblanky SLOD 3 and
blankblanky SLOQ 10 ,where σ is the standard deviation of the absorbance and S the 
signal of the blank sample. For LOQ a coefficient of variation (%CV) ≤ 20% for precision 
was accepted. 
 
 
11.5.3 Precision and accuracy 
 
The precision of an analytical method describes the closeness of repeated individual 
measures of analyte of the same homogenous sample under the same conditions and may 
be considered at three levels: repeatability (also referred as within-run or within-day or 
intraday precision), intermediate precision and reproducibility (expresses the precision 
between laboratories and only has to be studied, if a method is supposed to be used in 
different laboratories).  
Precision is expressed as the %CV. Intraday precision data was quantified by analysing 
the 3 replicates of three concentrations (low: 2%, medium: 30% and high: 90%) and 
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calculating the %CV. Absorbances of the same 3 concentrations, measured in 3 
consecutive days, were used to calculate the interday repeatability (%CV). A %CV value of 
≤15% for interday and intraday analysis was considered satisfactory. 
The accuracy of a method is affected by systematic (bias) as well as random (precision) 
error components. The accuracy of an analytical method describes the closeness of the 
determined value obtained by the method to the true concentration of the analytes 
(expressed in percentage). The intraday and interday accuracy of the method were 
evaluated by spiking blank matrix with three different carbon monoxide concentrations (low: 
2%, medium: 30% and high: 90%) and through the calculation of the deviation percentage 
between the calculated value and the nominal [Accuracy (%) = (experimental 
concentration/theoretical concentration) × 100]. A deviation percentage of ≤15% was 
considered satisfactory. 
 
11.6 Stability study 
 
The method used in stability study was based on the work of Luchini and collaborators 
(Luchini et al., 2009). 
All blood samples were collected in tubes with EDTA as anticoagulant and stored at 
different conditions. Two concentrations were considered to simulate a: 
a) Fatal intoxication - since  postmortem blood does not coagulate in the exact 
moment of death due to the existence of fibrinolysins that maintain postmortem blood fluid 
for a period of time after death, an anticoagulant was added to samples (Luchini et al., 2009; 
Mole, 1948; Mullertz, 1972); 
b) Non-fatal intoxication - blood was prepared in order to mimic a non-fatal CO 
poisoning, and also stored at different conditions. 
To mimic a fatal intoxication, 2 mL of blood with anticoagulant were bubbled with CO 
for 40 seconds and then added NaF, while the blood used to mimic the non-fatal intoxication 
did not have NaF and was bubbled with CO for 10 seconds. Both samples were bubbled 
with nitrogen for 2 minutes to remove any CO unbounded to Hb. 
In order to have a first value for comparison, 50 µL of blood of each pool were added 
to 6 mL of hemolytic solution and left for 10 minutes at RT to ensure total hemolysis. Then, 
200 µL of these solutions were transferred to other tubes containing 2.3 mL of reducing 
solution and left for 10 min to ensure complete reduction. 150 µL of these solutions were 
placed in the wells of a microplate and absorbance readings were made at 420 and 432 
nm. Reanalysis were performed in the same way. 
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Each pool was posteriorly divided in three aliquots of 2 mL each and stored at different 
temperatures: RT, -20ºC and 4ºC. 
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12. RESULTS AND DISCUSSION 
 
12.1 Preparation of calibrators at 100% O2Hb and COHb samples – bubbling times 
 
In order to infer about the time necessary to obtain saturated solutions with O2 and CO, 
a series of tests were performed, by bubbling solutions at different times and observe when 
the maximum was reached. Figure 4 shows the results obtain. 
 
 
Figure 4 – Preparation of solutions of COHb and O2Hb at 100%. 
By observation of the graphic, by bubbling a solution for 20 minutes with O2 the 
maximum of intensity is achieved at 432 nm. By bubbling a solution for 2 minutes with CO 
it is obtained a maximum at 420 nm, so the solution is saturated. These 100% concentrated 
O2Hb and COHb were then used to calculate F1, F2 and F3 factors. 
 
12.2 Calculated factors 
 
Calculated F1, F2 and F3 factors for method validation and stability studies are 
presented in Table 7. 
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Table 7 – Calculated factors in method validation and stability study. 
Factors 
Method 
Validation 
Stability study 
Samples with 
anticoagulant 
Samples with 
anticoagulant 
and NaF 
F1 1.19 1.178 0.453 
F2 0.52 0.7316 0.7320 
F3 1.70 1.501 0.623 
 
 
12.3 Method validation 
 
12.3.1 Linearity 
    
The weighted least squares linear regression equations and coefficients of 
determination were calculated using three independent curves. Results are presented as 
mean ± standard deviation and y and x represent the relationship between the %COHb and 
the corresponding absorbance readings. The determination coefficients were 0.9959 for 
420 nm and 0.9831 for 432 nm over the concentration range, confirming the linearity of the 
method (Figure 5). 
Figure 5 – Linearity study for n=3. 
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12.3.2 Limit of Detection and Limit of Quantification 
 
LOD and LOQ values ranged from 0.9-1.4%. Luchini and collaborators ((Luchini et al., 
2009) in their work obtained a LOQ of 0.1%. In the work of Cronenberg and collaborators, 
was obtained a LOQ of 0.3% (Cronenberger et al., 2007). Hao and collaborators obtained 
a LOQ of 0.2% in their work (Hao et al., 2013). 
 
12.3.3 Precision, accuracy and recovery 
 
Precision, accuracy and recovery results are presented in Table 8. As the %CV 
calculated for intra- and inter-day precision studies did not exceed 15%, the developed 
method was considered precise for the analyte. Accuracies were evaluated using the 
percentage of recoveries. Accuracies in the range of 86.1-117.3% for %COHb were 
obtained, which are within the proposed acceptance limits for this parameter (100 ± 20%) 
(European Medicines Agency, 2011).  
 
Table 8 – Results from precision and accuracy. 
Analyte 
Concentration 
(%) 
Intra-day 
precision (%, 
n=3) 
Inter-day 
precision (%, 
n=3) 
Accuracy 
(%, n=3) 
CO 
2 2.17 2.24 98.3 
30 1.55 1.02 116.6 
90 2.45 2.56 97.5 
 
 
12.4 Stability study 
 
In our study we attempted to evaluate the stability of the %COHb typically obtained in 
fatal and non-fatal intoxications. For non-fatal intoxication the initial value for posterior 
comparison was 27.4%. Table 9 shows the results obtained in all analysis and Figure 6 
shows the behavior of %COHb throughout time.  
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Table 9 - Stability of %COHb (non-fatal intoxication) at three different temperatures (RT, -
20ºC and 4ºC.) 
Temperature 
(ºC) 
Time (days) 
0 7 19 41 181 188 
RT 
27.4 
23.8 32.4 24.8 7.1 6.4 
-20 25.6 28.7 26.8 25.8 25.0 
4 24.1 28.7 25.0 27.4 26.9 
 
 
Figure 6: Evolution of %COHb throughout storage time for non-fatal intoxication sample. 
 
At RT, %COHb suffers quite alterations throughout time, decreasing until 6.4 % after 
the 6 months of the study. Noteworthy that besides being at RT these samples did not had 
NaF, so that could influence this decrease. Also, it is referred in literature that in samples 
with relatively low %COHb, concentration could decrease with time (Kunsman et al., 2000). 
Comparing all values, from day 1 to day 180, with the initial value (27.4%), the %COHb 
did not suffer alterations up to 6 months when stored at -20ºC. 
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At 4ºC, the behavior of %COHb is quite similar to that obtained at -20ºC – no oscillations 
occur during the time of study. This suggests that RT is not a suitable temperature for blood 
samples suspicious of containing CO so low temperatures, namely below 4ºC, must be 
used as a storage temperature.  
 
For fatal intoxications initial value obtained for posterior comparison was 76.2%. Table 
10 shows the results obtained in all analysis and figure 7 shows the behavior of %COHb 
throughout time.  
 
Table 10 – Stability of %COHb (fatal intoxication) at three different temperatures (RT, -20ºC 
and 4ºC.  
Temperature 
(ºC) 
Time (days) 
0 7 19 41 181 188 
RT 
76.2 
72.7 75.6 82.3 98.3 97.4 
-20 76.6 74.4 77.1 77.9 77.1 
4 79.2 75.3 78.8 77.7 77.0 
 
 
 
Figure 7: Evolution of %COHb throughout storage time for fatal intoxication sample. 
 
At RT, between day 0 (76.2%) and day 7 (72.7%) the difference was 3.5 %. Until day 
41, all the concentrations practically did not suffer alterations. From day 181 it was found a 
difference up to 22.1%, already descript in literature as a normal behavior of COHb when 
%COHb > 70-80% (Kunsman et al., 2000). RT storage may influence this increase.  
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At -20ºC, comparing all values to the initial one (76.2%) it is visible that no alterations 
occur in %COHb throughout time. -20ºC appears to be a better storage temperature than 
RT when it comes to blood samples containing CO. 
At 4ºC the behavior of %COHb throughout time is similar to that at -20ºC – no changes 
occur during the 6 months of study. 
When it comes to store blood samples suspicious of containing CO, low temperatures 
must be used, namely below 4ºC. Other studies performed led to similar results. Kunsman 
et al. (Kunsman et al., 2000) compared the stability of CO in postmortem blood samples 
collected in grey-top vacutainer tubes with and without NaF (the authors did not specified 
NaF concentration in the referred tubes) and stored at 3ºC during two years. In their study 
the addition of preservative did not significantly affect the %COHb and they conclude that 
no significant changes occurred. Hampson (Hampson, 2008) also tested the stability of 
COHb and showed that no significant changes occurred in %COHb in blood samples with 
heparin and without NaF, with COHb levels remaining stable during the time of the study 
(four weeks) with or without refrigeration at 4ºC or RT. 
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13. CONCLUSIONS 
 
A method for evaluation of %COHb in blood was validated by spectrophotometry 
UV/Vis. Linearity was verified in a concentration range from 0-100% of COHb, with r2 ≥ 
0.98. The method has shown to be precise and accurate with a LOD and LOQ varying from 
0.9-1.4%. 
In the stability study, the %COHb suffered no variation throughout time (6 months) at -
20°C and 4ºC, either for samples with and without NaF. RT is not a recommended storage 
temperature for blood samples containing CO. NaF seems not to have any relevance in the 
stability of CO in blood samples. 
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14. FUTURE PERSPECTIVES 
 
In order to further analyze CO stability more conditions should be study, namely 
different initial concentrations of CO in blood, different concentrations of NaF added to blood 
and study other temperatures of storage, to prove if CO is stable in other conditions than 
those evaluated in this work. 
Also a comparison between methods (e.g., spectrophotometry versus gas-
chromatography) could be made in order to compare the precision and accuracy of each 
and infer which one is the more suitable for CO analysis. 
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